International Psoriasis Council

International Psoriasis Council
subscribe
5   What's New
Search
subscribe
Search

Advancing Knowledge. Improving Care.

Alexander

Egeberg

,

MD, PhD, DMSc

Professor of Dermatology and Senior Consultant
University of Copenhagen and Bispebjerg Hospital
Copenhagen
,
Denmark
Request an Update
Dr. Alexander Egeberg is Professor of Dermatology (University of Copenhagen) and Senior Consultant at the Department of Dermatology at Bispebjerg Hospital, Copenhagen, Denmark, where he serves as the head of one of the largest psoriasis clinics in Northern Europe with more than 1,500 patients on biologic therapy, as well as the head of the psoriasis clinical trial unit. As a board-certified dermatologist, he earned his MD from the University of Southern Denmark and his PhD and doctoral degree of medical science (DMSc) from the University of Copenhagen. Dr. Egeberg also holds a post-graduate degree in Economics from Copenhagen Business School. Having authored more than 250 international scientific publications and several textbook chapters, he is an expert in inflammatory skin diseases with broad experience in epidemiology, real-world evidence, translational medicine, and clinical trials. From his involvement in global steering committees and as an investigator in numerous international clinical trial programs, he has extensive knowledge about drug development, has served on global Data Safety Monitoring Boards, and has been an acting advisor for the European Medicines Agency (EMA).
Last Updated:
10/26/2022

Areas of Interest

Epidemiology of psoriasis using large-scale administrative datasets, and questionnaire-based surveys; Efficacy and safety of systemic psoriasis therapies using real-world and clinical trial data. Harmonization of patient registries, guidelines.

Languages Spoken

Danish, English

Featured

Blog

Focus on Psoriasis: A Report from the 32nd European Academy of Dermatology and Venereology 2023 Congress (EADV).

Access the latest insights from the 32nd European Academy of Dermatology and Venereology 2023 Congress (EADV) in…

Read More

Blog

Commentary: Looking Beyond Plaque Psoriasis: Novel IL-36 Inhibitor for Prevention of Generalized Pustular Psoriasis…

Discover the latest in generalized pustular psoriasis (GPP) treatment with the approval of intravenous spesolimab by…

Read More

Video

Cutting Edge Systemic Treatments: Oral and Biologic.

Dr. Egeberg reviews the new oral and biologic treatments in development.

Watch Video

Blog

Focus on Psoriasis: A Report from the 2023 American Academy of Dermatology (AAD) Annual Meeting.

The 2023 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 16 – Tuesday, March 21, 2023,…

Read More

PDF

Focus on Psoriasis: A Report from the 2023 American Academy of Dermatology (AAD) Annual Meeting.

The 2023 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 16 – Tuesday, March 21, 2023,…

View Report

Event

Symposium: Psoriasis: Using the Right Treatment in the Right Patient at the Right Time.

AMERICAN ACADEMY OF DERMATOLOGY ANNUAL MEETING (AAD) | NEW ORLEANS, LA Thursday, March 16 14:00 - 17:00…

March 16, 2023
Learn More or Register

Blog

Focus on Psoriasis: A Report from the European Academy of Dermatology and Venereology 31st Annual Congress (EADV).

The European Academy of Dermatology and Venereology (EADV) organized its 31st congress in Milano, Italy, under the…

Read More

Blog

Commentary: Drug Survival Associated with Effectiveness and Safety of Treatment with Guselkumab, Ixekizumab,…

Real-world evidence studies become crucial to achieving the evidence needed in clinical practice. But how are data…

Read More

PDF

Focus on Psoriasis: A Report from the 7th Congress of the Skin Inflammation & Psoriasis International Network (SPIN).

Experts worldwide report on their experiences and deliver insight into the latest results and clinical studies. The…

View Report

Blog

Focus on Psoriasis: A Report from the 7th Congress of the Skin Inflammation & Psoriasis International Network (SPIN)…

The 7th Congress of the Skin Inflammation & Psoriasis International Network (SPIN) was held Wednesday, July 6 –…

Read More

PDF

Focus on Psoriasis – A Report from the 2021 Hybrid Gene to Clinic Congress.

View Report

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »
Monday, April 27, 2026

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026